University of Pennsylvania

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).

1,423 total trials 199 currently recruiting 982 completed early-phase tilt top decile by trial count

University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.

University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,423 total, page 28 of 29

COMPLETED Phase 4

Collaboration to Reduce Disparities in Hypertension

NCT00133068

COMPLETED NA

The Penn Lifestyle Modification and Blood Pressure Study

NCT00328666

COMPLETED Early Phase 1

Facilitators to Keeping Colonoscopy Appointments

NCT00431327

COMPLETED Phase 1

Preliminary Testing of New Treatment for Chronic Leg Wounds

NCT00000431

TERMINATED Phase 3

Periodontal Infection and Prematurity Study

NCT00116974

COMPLETED Phase 4

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

NCT00304161

COMPLETED Phase 2

Modafinil Treatment for Cocaine-Dependent Individuals

NCT00129285

COMPLETED Phase 4

Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina

NCT00194324

COMPLETED Phase 4

Comparison of Two Approaches to Weight Loss Follow-Up Study

NCT00143962

TERMINATED Phase 4

The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity

NCT00133029

COMPLETED NA

Mechanisms of Action of Acetaminophen

NCT00646906

COMPLETED Phase 3

Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation

NCT00364156

COMPLETED Phase 3

HIV Prevention Among Substance Abusing SMI

NCT00447720

COMPLETED NA

Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women

NCT00611533

COMPLETED Phase 3

Effectiveness of Extended Telephone Monitoring

NCT00194103

COMPLETED Phase 2

Testosterone and Growth Hormone for Bone Loss in Men

NCT00080483

COMPLETED Phase 2

Effects of Naltrexone on Nicotine Reinforcement

NCT00270231

COMPLETED Phase 2

The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure

NCT00791843

COMPLETED Phase 3

Community-Based Cognitive Therapy for Suicide Attempters

NCT00081367

COMPLETED Phase 4

Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR

NCT00183274

COMPLETED NA

Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples

NCT00644163

COMPLETED

Medication Treatment for Depression in Nursing Home Residents

NCT00076622

COMPLETED

Serum and Peritoneal Fluid Bank for Endometriosis Markers

NCT00194233

COMPLETED Phase 4

Managing Alcoholism in People Who Do Not Respond to Naltrexone

NCT00115037

COMPLETED NA

Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea

NCT00089752

COMPLETED Phase 2

Comparing Smoking Treatment Programs for Lighter Smokers - 1

NCT00086411

COMPLETED NA

Inflammation and the Metabolic Syndrome in Humans

NCT00954824

COMPLETED

Cognitive Impairement In Frontotemporal Dementia

NCT03452956

COMPLETED NA

A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation

NCT00434694

COMPLETED Phase 3

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

NCT00078130

COMPLETED

Cytomegalovirus (CMV) Infection in Pregnancy

NCT00194155

COMPLETED Phase 3

Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.

NCT00124059

TERMINATED NA

Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin Sheath

NCT00194181

COMPLETED NA

Genetic Counseling in African American Women

NCT00419510

TERMINATED Phase 4

Magnesium Sulfate Versus Indomethacin for Preterm Labor

NCT00116623

COMPLETED NA

Walking For Wellness Program Evaluation

NCT00156351

COMPLETED

Research Study on the Effects of Smoking on Arteries

NCT00948454

COMPLETED NA

Nicotine Patch, Blood Flow and Oxidative Stress Study

NCT00954096

COMPLETED

Infertility Markers in Serum, Urine, and Follicular Fluid

NCT00194220

COMPLETED Phase 3

Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents

NCT00360451

TERMINATED NA

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

NCT00906035

COMPLETED NA

Weight Management Skills in African American Outpatients

NCT00146081

COMPLETED Phase 2

Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault

NCT00057629

COMPLETED Phase 3

Treatments for Depression: Drug Versus Psychotherapy

NCT00043550

COMPLETED NA

Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents

NCT00640653

COMPLETED Phase 2

Relationship Between the Biological and Psychological Correlates of PTSD

NCT00183300

COMPLETED

Factor V Leiden Mutation and Implantation Failure

NCT00194350

COMPLETED Phase 1

CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients

NCT01013415

COMPLETED

Treatment Outcome of Vascular Depression

NCT00045773

COMPLETED Phase 3

Two-Dose Methotrexate for Ectopic Pregnancy

NCT00194272

← Previous Page 28 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 182
Phase 2 157
Phase 3 43
Phase 4 87

What is open in the University of Pennsylvania pipeline

199 recruiting of 1,423 indexed (14% open); 982 completed (69%).

Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.